Our scientific "learning/confirming" approach to drug development presents a unique way to conceptualise and formulate the development of a product, which can help save time and spearhead regulatory success.

> Reduce Development Time & Cost
> Faster Time to Market & Product Launch
> Increased Return On Investment

Based on this innovative approach Triskel:

· Provides high quality, integrated and customized strategic expertise.

· Crafts innovative development plans and negotiates effective regulatory strategies.

· Implements development plans working through Steering Committees with the client to guide and monitor CROs or other development partners.

· Orchestrates, prepares and completes regulatory filings in EU and US.

· Encompasses all expertise necessary to register medicinal products in European and US markets.

Is a strategic complement to CROs, contract manufacturers or other classical service providers.